23andMe (ME) also announced that Anne Wojcicki is resigning from her role as CEO, effective immediately, by mutual agreement between Wojcicki and the special committee. Wojcicki will continue to serve as a member of 23andMe’s board. The board has appointed Joe Selsavage, chief financial and accounting officer, to the additional role of interim CEO and Matt Kvarda, a managing director at Alvarez & Marsal, as chief restructuring officer. In addition, Thomas Walper, a former partner in the financial restructuring practice at Munger, Tolles & Olson LLP, was appointed to 23andMe’s board and the special committee as an independent director. Jensen has been appointed chair of the board.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ME:
- 23andMe Stock (ME) Files for Bankruptcy Amid Co-Founder/CEO’s Departure
- 23andMe launches new homocysteine genetic report, lab test
- 23andMe (ME) Stock Nosedives After Board Rejects CEO’s Takeover Offer
- 23andMe rejects acquisition proposal from CEO Anne Wojcicki
- 23andMe launches new genetic report on osteoporosis